
Nexmoir-S Injection
Marketer
H & I Critical Care
Salt Composition
Meropenem (1000mg) + Sulbactam (500mg)
Overview Nexmoir-S Injection
Combiflox Injection is a dual-action medication indicated for diverse bacterial infections. Its mechanism combats microbial proliferation. Administration of Combiflox Injection must be solely under a physician's guidance. Strict adherence to the prescribed dosage schedule is crucial; complete the entire course, regardless of symptom improvement. Typical side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (redness, swelling, pain), generally resolving spontaneously. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) demand prompt emergency care. Prior to commencing treatment, inform your doctor of all concurrent medications and pre-existing health conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs.
Primary Ingredients of Nexmoir-S Injection
There is no text provided to rephrase.
Uses of Nexmoir-S Injection
Life-threatening bacterial infections
Major Benefits of Nexmoir-S Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Nexmoir-S Injection:
- Nausea
- Vomiting
- Diarrhea
- Headache
- Rash
How to use Nexmoir-S Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
How Nexmoir-S Injection works:
Nexmoir-S Injection combines Meropenem, an antibiotic, with Sulbactam, a beta-lactamase inhibitor. Meropenem's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial survival. Sulbactam counteracts bacterial enzymes that would otherwise neutralize Meropenem, thus improving Meropenem's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Nexmoir-S Injection concurrently with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The use of Nexmoir-S Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The administration of Nexmoir-S Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Nexmoir-S Injection on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with kidney impairment, administration of Nexmoir-S Injection requires careful consideration. Dosage modification of Nexmoir-S Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Nexmoir-S Injection use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Nexmoir-S Injection :
Omitting a scheduled dose of Nexmoir-S Injection warrants immediate physician consultation.
Facts to Know About Nexmoir-S Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
